GMV 0.00% 3.9¢ g medical innovations holdings limited

Ann: Notice of Annual General Meeting, page-11

  1. 729 Posts.
    lightbulb Created with Sketch. 596
    So a cap raise at current market levels would be 960million shares on issue and a market cap of $50million AUD and infact makes market cap calculations pretty easy going forward (HA).

    They've at least given us a breakdown of where the capital is going:

    Expanding US Sales team A$2mio

    R&D (PRIZMA G3) 1.2mio

    Production of $7mio

    Monitoring and infrastructure $2mio

    and working capital $2mio.

    Will see what the 4c brings, very hard to get a read on how sales are going, whether the IDTF facilities have normalised or any other progress with current opportunities. Given current information id say this gets raised below 5c a share

    Unfortunately, to get the company to a position where it can grow and is not hampered by cash constraints, i think they do need a raise of this size. My issue with the company is execution - but if they dont raise, this could likely just fade away into darkness.

    In startup terms, this looks like a Series B where the company is gaining some traction with products and needs the growth capital to accelerate sales.

    This one is for the long haul now given that dilution

 
watchlist Created with Sketch. Add GMV (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.